Found: 8
Select item for more details and to access through your institution.
Looking for A Place for Dose-Dense TMZ Regimens in GBM Patients: An Experience with MGMT Exploratory Evaluation.
- Published in:
- Bioengineering (Basel), 2019, v. 6, n. 1, p. 1, doi. 10.3390/bioengineering6010011
- By:
- Publication type:
- Article
Expression profile of HLA‐B*38:55Q allele.
- Published in:
- HLA: Immune Response Genetics, 2020, v. 95, n. 5, p. 449, doi. 10.1111/tan.13790
- By:
- Publication type:
- Article
Intensive first-line FIr-C/FOx-C association of triplet chemotherapy plus cetuximab in RAS wild-type metastatic colorectal cancer patients: preliminary phase II data and prediction of individual limiting toxicity syndromes by pharmacogenomic biomarkers.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919846421
- By:
- Publication type:
- Article
Intensive first-line FIr-C/FOx-C association of triplet chemotherapy plus cetuximab in RAS wild-type metastatic colorectal cancer patients: preliminary phase II data and prediction of individual limiting toxicity syndromes by pharmacogenomic biomarkers.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919846421
- By:
- Publication type:
- Article
Prognostic value of KRAS genotype in metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx) according to extension of metastatic disease.
- Published in:
- BMC Medicine, 2012, v. 10, n. 1, p. 135, doi. 10.1186/1741-7015-10-135
- By:
- Publication type:
- Article
Anthracycline-Free Neoadjuvant Treatment in Patients with HER2-Positive Breast Cancer: Real-Life Use of Pertuzumab, Trastuzumab and Taxanes Association with an Exploratory Analysis of PIK3CA Mutational Status.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 3003, doi. 10.3390/cancers14123003
- By:
- Publication type:
- Article
Weekly alternate intensive regimen FIrB/FOx in metastatic colorectal cancer patients: an update from clinical practice.
- Published in:
- OncoTargets & Therapy, 2019, v. 12, p. 2159, doi. 10.2147/OTT.S194745
- By:
- Publication type:
- Article
External Quality Assessment (EQA) program for the preanalytical and analytical immunohistochemical determination of HER2 in breast cancer: an experience on a regional scale.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2013, v. 32, n. 1, p. 1, doi. 10.1186/1756-9966-32-58
- By:
- Publication type:
- Article